We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Champions Oncology Inc (CSBR) USD0.001

Sell:$4.63 Buy:$5.80 Change: $0.04 (0.81%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Sell:$4.63
Buy:$5.80
Change: $0.04 (0.81%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Sell:$4.63
Buy:$5.80
Change: $0.04 (0.81%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Champions Oncology, Inc. is a technology-enabled research organization engaged in creating transformative technology solutions to be utilized in drug discovery and development. The Company's research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The Company’s TumorGraft Technology Platform (The Platform) provides select services to pharmaceutical and biotechnology companies. Its software as-a-service business is centered around its software platform and data tool, Lumin Bioinformatics (Lumin), which contains comprehensive information derived from its research services and clinical studies. Its drug discovery and development business leverage the computational and experimental capabilities within its platforms. Its discovery strategy utilizes its datacenter, coupled with artificial intelligence and other advanced computational analytics, to identify therapeutic targets.

Contact details

Address:
SUITE 619, 855 N. WOLFE STREET
BALTIMORE
21205
United States
Telephone:
+1 (410) 3690365
Website:
https://championsoncology.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CSBR
ISIN:
US15870P3073
Market cap:
$67.15 million
Shares in issue:
13.59 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Brady Davis
    President
  • Ronnie Morris
    Chief Executive Officer, Director
  • David Miller
    Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.